97 results
Page 2 of 5
8-K
EX-99.1
t2y1qixg 3t9z0no
7 Aug 23
Viatris Reports Strong Financial and Operational Results for Second Quarter 2023 and Return of Capital to Shareholders
7:38am
8-K
EX-99.2
bgtng67k6u1
22 May 23
Coury will serve in this new role until the end of 2025
7:46am
8-K
EX-99.1
xgwm 14gqg
22 May 23
Coury will serve in this new role until the end of 2025
7:46am
8-K
jafnecr5s4 q6
22 May 23
Coury will serve in this new role until the end of 2025
7:46am
8-K
EX-99.1
rzhvbps4 2oe8qfif
8 May 23
Viatris Reports Strong Financial and Operational Results for First Quarter 2023 and Return of Capital to Shareholders
7:51am
8-K
EX-99.1
o14fnwpko1e30
29 Dec 22
Viatris Announces Appointments of Scott A. Smith and Elisha W. Finney
4:14pm
SC TO-T
EX-99
jds94a1 2wo3xit
1 Dec 22
Third party tender offer statement
6:06am
8-K
bitfy 5f2
29 Nov 22
Viatris Completes Biosimilars Transaction with Biocon Biologics
8:29am
8-K
EX-99.1
lsni8651
29 Nov 22
Viatris Completes Biosimilars Transaction with Biocon Biologics
8:29am
SC TO-C
qaob3k
14 Nov 22
Information about tender offer
8:09am
SC TO-C
EX-99.1
jb57t
14 Nov 22
Information about tender offer
8:09am
SC TO-C
EX-99.1
5pqtxsdco1
8 Nov 22
Information about tender offer
6:06am
SC TO-C
o801b0r
8 Nov 22
Information about tender offer
6:06am
SC TO-C
gkb6sd2sdl6
7 Nov 22
Information about tender offer
5:26pm
SC TO-C
EX-99.2
5q0kknwzeo
7 Nov 22
Information about tender offer
5:26pm
SC TO-C
EX-99.1
rzlmndtq
7 Nov 22
Information about tender offer
5:26pm